Journals / Toraks Dergisi / 2000 / Cilt: 1 - Sayı: 2

Investigation of susceptibility in Mycobacterium tuberculosis isolates to amoxycillin-clavulanate by using E-test

Mycobacterium tuberculosis izolatlarının amoksisilin-klavulanik aside karşı duyarlılıklarının E-test yöntemiyle araştırılması

Pages
28–31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

According to the results of our study, amoxycillin-clavulanate combination has effective antimycobacterial activity especially against the susceptible strains.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In vitro susceptibility of 40 Mycobacterium tuberculosis isolates to amoxycillin-clavulanate, which were isolated from various clinical specimens and 33 of which were susceptible to first line-drugs and 7 of resistant to more than one antimycobacterial agents were investigated by using E-test.
📊
Key Findings & Data:It was determinated that MIC50 and MIC90 values of amoxycillin-clavulanate for susceptible strains were 8 mg/ml and 96 mg/ml, respectively.
💡
Conclusion & Impact:According to the results of our study, amoxycillin-clavulanate combination has effective antimycobacterial activity especially against the susceptible strains.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:İlaç direnci · Tüberküloz · İlaç kombinasyonları

Abstract

In vitro susceptibility of 40 Mycobacterium tuberculosis isolates to amoxycillin-clavulanate, which were isolated from various clinical specimens and 33 of which were susceptible to first line-drugs and 7 of resistant to more than one antimycobacterial agents were investigated by using E-test. It was determinated that MIC50 and MIC90 values of amoxycillin-clavulanate for susceptible strains were 8 mg/ml and 96 mg/ml, respectively. These values in multiple-drug resistant M. tuberculosis isolates were found as 48 mg/ml and 256 mg/ml, respectively. According to the results of our study, amoxycillin-clavulanate combination has effective antimycobacterial activity especially against the susceptible strains.

Özet

Çeşitli klinik örneklerden izole edilmiş 33'ü birinci sıra ilaçlara duyarlı, 7'si birden fazla antimikobakteriyel ilaca dirençli toplam 40 Mycobacterium tuberculosis izolatının amoksisilin-klavulanik aside karşı in vitro duyarlılığı E-test yöntemiyle araştırıldı. Amoksisilin-klavulanik asit kombinasyonunun duyarlı kökenlere karşı MİK50 ve MİK90 değerleri sırasıyla 8 mg/ml ve 96 mg/ml olarak saptandı. Çoğul ilaç dirençli tüberküloz (ÇİD-tb) izolatlarında ise bu değerler sırasıyla 48 mg/ml ve 256 mg/ml bulundu. Çalışmamız sonuçlarına göre amosisilin-klavulanik asit kombinasyonunun özellikle duyarlı kökenlere karşı etkin bir bakterisid aktivite gösterdiği saptandı.

🔖

Cite This Article

ŞANLIDAĞ, T., AKÇALI, S., ÖZKÜTÜK, N., ÖZBAKKALOĞLU, B. (2000). Investigation of susceptibility in Mycobacterium tuberculosis isolates to amoxycillin-clavulanate by using E-test. Toraks Dergisi, Cilt: 1 - Sayı: 2, 28–31. https://ajindex.com/articles/368046

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Cohn DL, Bustreo F, Raviglioni MC. Drug-resistant tuberculosis: Review of the worldvide situtation and the WHO/IUATLD global surveillance project. Clin Infect Dis 1997; 24 (suppl 1): 121-30
  2. Mendez AP, Raviglione MC, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance, 1994-1997. N Eng J Med 1998; 338: 1641-9
  3. Çımrın AH. Tüberküloz tedavisinde gelişmeler. ANKEM Derg 1994; 8: 217-23
  4. Segura C, Salvado M, Collado I, et al. Contribution of b-lactamases to b-lactam susceptibilities of susceptible and multidrug-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother 1998; 42:1524-6. [ Özet ] [ Benzer Makaleler ] 5). Bush K, Jacoby GA, Medeiros AA. A functional classificaion scheme for b-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995; 39: 1211-33. [ Özet ] [ Benzer Makaleler ] 6) Chambers HF, Kocagöz T, Sipit T, et al. Activity of amoxicillin/clavulanate in patients with tuberculosis. Clin Infect Dis 1998; 26: 874-7. [ Özet ] [ Benzer Makaleler ] 7) Akçalı S. Manisa bölgesinden soyutlanan Mycobacterium tuberculosis izolatlarının birinci kuşak antitüberküloz ilaçlara in vitro duyarlılıkları. Uzmanlık Tezi. S.41, 2000, Manisa
  5. Wanger A, Mills K. E-test for susceptibility testing of Mycobacterium tuberculosis and Mycobacterium avium-intracellulare. Diagn. Microbiol Infect Dis 1994; 19: 179-81
  6. Hoffner SE, Klintz L, Olsson-Liljequist B, Bolmström A. Evaluation of Etest for rapid susceptibility testing of Mycobacterium chelonae and M. fortuitum. J Clin Microbiol 1994; 32: 1846-9. [ Özet ] [ Benzer Makaleler ] 10) Biehle JR, Cavalieri SJ, Saubolle MA, Getsinger LJ. Evaluation of Etest for susceptibility testing of rapidly growing Mycobacteria. J Clin Microbiol 1995; 33: 1760-4. [ Özet ] [ Benzer Makaleler ] 11) Akcan Y, Tuncer S, Ünal S. Çoklu ilaca dirençli tüberküloz. İlaç ve Tedavi Dergisi 1997; 10; 25-29
  7. Pfaller MA. Applications of new technology to the detection, identification, and antimicrobial susceptibility testing of Mycobacteria. Am J Clin Pathol 1994; 101:329-37. [ Özet ] [ Benzer Makaleler ] 13) Salfinger M, Pfyffer GE. The new diagnostic mycobacteriology laboratory. Eur J Clin Microbiol Infect Dis 1994; 13: 961-79. [ Özet ] [ Benzer Makaleler ] 14) Chen CH, Yang MH, Lin JS, et al. The in vitro activity of beta-lactamase inhibitors in combination with cephalosporins against M.tuberculosis. Proc Natl Sci Counc Repub China B 1995; 19: 80-4. [